Designing RSV effectiveness studies in LMICs – lessons from rotavirus and pneumococcal

During the 19th webinar of ReSViNET’s RSV Webinar Series, Dr. Rita Reyburn, shares her insights on Designing RSV effectiveness studies in LMICs – lessons from rotavirus and pneumococcal. Dr. Rita Reyburn is an international public health epidemiologist with over 18 years of experience in communicable disease control and vaccine evaluation in low- and middle-income countries (LMICs). She has led post-licensure effectiveness and impact studies for pneumococcal, rotavirus, HPV, and meningococcal vaccines, with a strong focus on translating evidence into policy and practice.